[Multicenter trials of a new cephalosporin (ceftriaxone) in childhood].
AA. have tested a new drug (Ceftriaxone) on 40 children affected by upper and lower respiratory tract infectious diseases. As shown by results, this new drug has been remarkably effective and easy to use since it may be administered once in a day; moreover, the tested drug has not caused any kind of tissue or parenchymal involvement.
D002443:Ceftriaxone / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006403:Hematologic Tests; D006801:Humans; D007223:Infant; D008297:Male; D012141:Respiratory Tract Infections / Q000097:blood / Q000188:drug therapy*
D002443:Ceftriaxone
Sperimentazione policentrica di una nuova cefalosporina (Ceftriaxone) in pediatria.